Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL3258305

CCCC[N+](CCCC)(CCCC)CCCC.O=C1[N-]S(=O)(=O)c2ccccc21

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.43
CA9 Q16790 4/20 0.43
PTPN1 P18031 1/20 0.36
ALDH1A1 P00352 2/20 0.35
CYP2C19 P33261 1/20 0.35
SLC22A1 O15245 1/20 0.35
GAA P10253 1/20 0.35
ELANE P08246 2/20 0.34
PKM P14618 1/20 0.34
ALDH2 P05091 1/20 0.33
ALDH3A1 P30838 1/20 0.33
CES1 P23141 2/20 0.33
CDC25A P30304 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cetrimonium SCHEMBL8526166 0.87 CA12 (0.41) CA12CA9PTPN1ALDH1A1CYP2C19
Saccharin SCHEMBL8668442 0.79 GPR3 (0.44) CA12CA9ALDH1A1ELANELMNA
Saccharin SCHEMBL10399957 0.79 GPR3 (0.44) CA12CA9ALDH1A1ELANELMNA
Saccharin SCHEMBL5870938 0.79 GPR3 (0.44) CA12CA9ALDH1A1ELANELMNA
Saccharin SCHEMBL953945 0.79 GPR3 (0.44) CA12CA9ALDH1A1ELANELMNA
Saccharin SCHEMBL10618576 0.79 GPR3 (0.44) CA12CA9ALDH1A1ELANELMNA
Saccharin SCHEMBL787894 0.79 GPR3 (0.44) CA12CA9ALDH1A1ELANELMNA
Saccharin SCHEMBL473608 0.79 GPR3 (0.44) CA12CA9ALDH1A1ELANELMNA
Saccharin SCHEMBL49027 0.79 GPR3 (0.44) CA12CA9ALDH1A1ELANELMNA
Saccharin SCHEMBL176171 0.79 GPR3 (0.44) CA12CA9ALDH1A1ELANELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230090768-A1 PROCESS FOR DIRECT SULFATION OF POLYSACCHARIDES IN AN ECOLOGICALLY ACCEPTABLE SOLVENT LESAFFRE ET COMPAGNIE (FR) 2023-03-23 US disclosed
EP-4114869-A1 PROCESS FOR DIRECT SULFATION OF POLYSACCHARIDES IN AN ECOLOGICALLY ACCEPTABLE SOLVENT Lesaffre et Compagnie (FR) 2023-01-11 EP disclosed
CN-115210266-A Process for the direct sulphation of polysaccharides in ecologically acceptable solvents 乐斯福公司 2022-10-18 CN disclosed
WO-2021176341-A1 PROCESS FOR DIRECT SULFATION OF POLYSACCHARIDES IN AN ECOLOGICALLY ACCEPTABLE SOLVENT LESAFFRE ET COMPAGNIE (FR) 2021-09-10 WO disclosed
EP-0497525-B2 Pneumococcal polysaccharide conjugate vaccine MERCK & CO INC (US) 2010-03-03 EP disclosed
EP-0897427-B1 POLYSACCHARIDE PRECIPITATION PROCESS MERCK & CO INC (US) 2004-10-27 EP disclosed
CN-1080124-C Pneumococcal polysaccharide conjugate vaccine MEREK & CO INC (US) 2002-03-06 CN disclosed
US-5847112-A Process for making capsular polysaccharides from Streptococcus pneumoniae MERCK & CO., INC. (US) 1998-12-08 US disclosed
EP-0497525-B1 Pneumococcal polysaccharide conjugate vaccine MERCK & CO INC (US) 1998-08-19 EP disclosed
EP-0497524-B1 Polysaccharide antigens from streptococcus pneumoniae MERCK & CO INC (US) 1998-07-15 EP disclosed
US-5623057-A IMMUNOGENIC PROTEIN COVALENTLY LINKED TO POLYSACCHARIDE DERIVED FROM STREPTOCOCCUS PNEUMONIAE MERCK & CO., INC. (US) 1997-04-22 US disclosed
CN-1064217-A PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE MERCK & CO INC (US) 1992-09-09 CN disclosed
EP-0497524-A2 Polysaccharide antigens from streptococcus pneumoniae MERCK & CO. INC. (US) 1992-08-05 EP disclosed